Purchase Order HT941023P0007
- Not listed
- The Defense Health Agency (DHA) awarded a $244,725 firm fixed-price purchase order to Hologic Sales And Service, LLC, a division of Hologic, Inc., for the procurement of SARS-CoV-2 test kits, controls, and related specimen collection supplies. The award includes 30 Aptima SARS-CoV-2 assay kits (250 tests each), 45 Aptima SARS-CoV-2 controls, and 75 specimen lysis tubes. Hologic, Inc. is a medical technology company that provides a range of products and services to federal agencies, including the...
- The U.S. Defense Health Agency awarded a $249,800 firm-fixed-price purchase order to Hologic, Inc. to provide the APTIMA SARS-COV-2 ASSAY TEST AND CONTROLS. The contract was awarded on January 7, 2022 with a completion date of February 15, 2022. Hologic, Inc. is a medical technology company that provides a range of diagnostic testing products, including reagents and consumables for molecular diagnostics platforms used across the Department of Veterans Affairs (VA) and Department of Defense (DoD)...
- This is a delivery order under contract W81K0421D0010 awarded by the Defense Health Agency (DHA) to Hologic Sales And Service, LLC, a division of Hologic, Inc. The $337,906.20 fixed-price contract is for the delivery of 250-test SARS-CoV-2 assay kits to support DHA operations through September 30, 2024. Hologic, Inc. is a leading medical technology company that provides a range of healthcare products and services to federal agencies including the Department of Veterans Affairs (VA) and...
- This federal contract award to Hologic Sales And Service, LLC, a subsidiary of Hologic, Inc., is for the provision of SARS-COV-2 assay kits. The $77,300 Firm Fixed Price Delivery Order was issued by the Defense Health Agency (DHA), a defense agency, and has a period of performance through September 30, 2025. The contract does not have a set-aside designation. In addition to this award, Hologic Sales And Service holds two larger indefinite-delivery/indefinite-quantity (IDIQ) contracts with the...
- Hologic, Inc. was awarded a $159,800 firm fixed-price delivery order for APTIMA SARS-COV-2 ASSAY tests by the Defense Health Agency (DHA). Under this contract, Hologic will provide its APTIMA SARS-COV-2 molecular diagnostic assay to test for COVID-19. The tests are to be delivered to a location in Marlborough, Massachusetts by May 22, 2021. The contract was awarded on May 11, 2021 under the DHA's Coronavirus COVID-19 national interest program without a set-aside designation. As the healthcare...
- This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Hologic Sales and Service, LLC, a subsidiary of Hologic, Inc. The contract is for the delivery of APTIMA SARS-COV-2 FFP products, with a completion date of December 28, 2022, and a ceiling value of $76,150.00. Hologic, Inc. is a leading medical technology company that specializes in advanced healthcare solutions for federal government agencies, including the Department of Veterans Affairs (VA) and the...
- This federal contract award to Hologic Sales And Service, LLC, a subsidiary of Hologic, Inc., is for $769,040.00 to provide SARS-CoV-2 assay kits in support of COVID-19 patient testing. The contract is a Blanket Purchase Agreement (BPA) call, with a firm fixed price and a period of performance ending on September 30, 2021. The funding agency is the Defense Health Agency, a defense agency. The contract was not set aside for any specific business classification. Hologic, Inc. is a leading...
- The Defense Health Agency awarded a firm fixed-price purchase order to Hologic Sales and Service, LLC on November 15, 2023, for SARS-CoV-2 assay kits in 250-test configurations. The contract carries a ceiling value of $4.7 million with an ultimate completion date of September 30, 2028, and will be performed in Jacksonville, North Carolina. This award supports the Defense Health Agency's diagnostic testing capabilities and reflects the agency's ongoing need for COVID-19 testing supplies within...
- <p>The Defense Health Agency (DOD) awarded a $412,230 firm fixed price delivery order contract to Hologic, Inc. for COVID assays. The contract will be performed by Hologic Inc.'s Marlborough, Massachusetts division from January 11, 2022 through February 18, 2022. Hologic, Inc. will provide COVID-19 diagnostic testing products and services to support the Defense Health Agency's pandemic response efforts. No subcontractors were identified.</p>
- This federal contract award to Hologic Sales And Service, LLC, a subsidiary of Hologic, Inc., is for the procurement of the HOLOGIC APTIMA SARS-COV-2 ASSAY for the Navy Medical Center San Diego. The contract, with a ceiling value of $283,150.00, is a firm-fixed-price purchase order awarded by the Defense Health Agency (DHA), a defense agency. The contract has no set-aside designation and is scheduled for completion by April 12, 2023. Hologic, Inc. is a leading medical technology company that...
The U.S. Defense Health Agency (DHA) awarded a $606,712 firm-fixed-price purchase order to Hologic Sales And Service, LLC, a subsidiary of Hologic, Inc., for the supply of APTIMA SARS-CoV-2 assay kits and reagents to support the Naval Hospital Bremerton. This contract has an ultimate completion date of December 23, 2023 and was not set aside for any specific business type. Hologic, Inc. is a medical technology company that provides a wide range of medical products and services, including medical imaging equipment, molecular diagnostic platforms, and associated maintenance support, to various federal agencies such as the Department of Veterans Affairs (VA) and Department of Defense (DoD). The company holds several Indefinite Delivery Vehicles (IDVs) with these agencies, demonstrating its ability to secure long-term contracts for specialized medical technology and diagnostic supplies.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Pylarity Injection Supplies (Master BPA) at Naval Medical Center San Diego | HT941023N0007 | Department of the Navy Naval Supply Systems Command | Solicitation 1/2 | 1/3/23, 1:05 PM | |
BPA Pylarify Injection | HT941023N0007 | Department of the Navy Naval Supply Systems Command | Solicitation 2/2 | 1/31/23, 11:31 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Supplemental Agreement for work within scope | $108.5k | 3/23/23 | |
| Not listed | Not listed | $121.3k | 11/23/22 |